Poland – General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents – Dostawa produktu leczniczego – Vorasidenib - DZP.242.215.2026
Opportunity Score
Confidence: 40%
Complexity: low
7 days
Deadline
supplies
Contract
Deep Portfolio Analysis
- Company fit score
- Missing certificates
- Eligibility blockers
- Bid / No-Bid recommendation
AI Analysis Summary
Single-lot open tender for the supply of the medicinal product Vorasidenib to a university hospital in Wrocław, Poland. Award based solely on lowest price. No estimated value provided. Bidders must hold a wholesale pharmaceutical permit and be registered in the relevant trade register. Submission via electronic platform, only in Polish.
Strengths
Documents available
Open procedure
Low complexity
Risks
Submission deadline in 7 days
Key Requirements
- Submission must be via the electronic platform (Open portal).
- Offers must be submitted in Polish.
- Bid validity until 2026-09-19 (90 days).
Award Criteria
Cena
1. Za ofertę najkorzystniejszą zostanie uznana oferta zawierająca najniższą cenę: „Cena” – C;
| Criterion | Type |
|---|---|
Cena 1. Za ofertę najkorzystniejszą zostanie uznana oferta zawierająca najniższą cenę: „Cena” – C; | Price |
Buyer
Name
UNIWERSYTECKI SZPITAL KLINICZNY IM. JANA MIKULICZA-RADECKIEGO WE WROCŁAWIU
Location
Wrocław, POL
Website
Buyer profile
Identifier
8981816856
Lots (1)
Supply of Vorasidenib for 12 months. Single task. No options or renewals.
Procurement Details
Publication
20 May 2026
Deadline
22 Jun 2026, 10:00
Procedure
open
Contract
supplies
Duration
12 MONTH
Language
POL
Publication #
347217-2026
Classification
Performance: Poland
Documents (2)
Opportunity Score
Confidence: 40%
Complexity: low
7 days
Deadline
supplies
Contract
Deep Portfolio Analysis
- Company fit score
- Missing certificates
- Eligibility blockers
- Bid / No-Bid recommendation